Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 47, 2018 - Issue 7
135
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Serum of Patients with Psoriasis Modulates the Production of MMP-9 and TIMP-1 in Cells of Monocytic Lineage

ORCID Icon, , , , , , , & show all

References

  • Ahad T, Agius E. (2015). The Koebner phenomenon. Br J Hosp Med (Lond), 76, C170–2. doi:10.12968/hmed.2015.76.11.C170
  • Baliwag J, Barnes DH, Johnston A. (2015). Cytokines in psoriasis. Cytokine, 73, 342–350. doi:10.1016/j.cyto.2014.12.014
  • Boehncke W-H. (2015). Etiology and pathogenesis of psoriasis. Rheum Dis Clin America, 41, 665–675. doi:10.1016/j.rdc.2015.07.013
  • Brew K, Dinakarpandian D, Nagase H. (2000). Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta, 1477, 267–283.
  • Brunner S, Kim J-O, Methe H. (2010). Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease. Am J Cardiol, 105, 429–434. doi:10.1016/j.amjcard.2009.10.013
  • Buommino E, De Filippis A, Gaudiello F, et al. (2012). Modification of osteopontin and MMP-9 levels in patients with psoriasis on anti-TNF-α therapy. Arch Dermatol Res, 304, 481–485. doi:10.1007/s00403-012-1251-3
  • Dai Y-J, Li -Y-Y, Zeng H-M, et al. (2014). Effect of pharmacological intervention on MIP-1α, MIP-1β and MCP-1 expression in patients with psoriasis vulgaris. Asian Pac J Trop Med, 7, 582–584. doi:10.1016/S1995-7645(14)60098-5
  • Eberle FC, Brück J, Holstein J, et al. (2016). Recent advances in understanding psoriasis. F1000Res, 5, 770. doi:10.12688/f1000research.7927.1
  • Fredriksson T, Pettersson U. (1978). Severe psoriasis–oral therapy with a new retinoid. Dermatologica, 157, 238–244. doi10.1159/000250839
  • Galeh EG, Meysam Abtahi H, Froushani S, et al. (2018). Effects of educated monocytes with xenogeneic mesenchymal stem cell–derived conditioned medium in a mouse model of chronic asthma. Immunol Invest, 1–17. doi:10.1080/08820139.2018.1458108
  • Kamal A, Elgengehy FT, Abd Elaziz MM, et al. (2017). Matrix metalloproteinase-9 rs17576 gene polymorphism and Behçet’s disease: is there an association? Immunol Invest, 46, 460–468. doi:10.1080/08820139.2017.1296857
  • Leonardi CL, Unnebrink K, Valdecantos WC. (2016). Reduction in C-reactive-protein levels with adalimumab therapy in patients with moderate-to-severe hand and/or foot psoriasis. J Drugs Dermatol, 15, 562–566.
  • Lowes MA, Suárez-Fariñas M, Krueger JG. (2014). Immunology of psoriasis. Annu Rev Immunol, 32, 227–255. doi:10.1146/annurev-immunol-032713-120225
  • Mezentsev A, Nikolaev A, Bruskin S. (2014). Matrix metalloproteinases and their role in psoriasis. Gene, 540, 1–10. doi:10.1016/j.gene.2014.01.068
  • Nestle FO, Kaplan DH, Barker J. (2009). Psoriasis. N Engl J Med, 361, 496–509. doi:10.1056/NEJMra0804595
  • Onumah N, Kircik LH. (2012). Psoriasis and its comorbidities. J Drugs Dermatol, 11, s5–10.
  • Parisi R, Symmons DPM, Griffiths CEM, Ashcroft DM. (2013). Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Investigative Dermatol, 133, 377–385. doi:10.1038/jid.2012.339
  • Sabat R, Philipp S, Höflich C, et al. (2007). Immunopathogenesis of psoriasis. Exp Dermatol, 16, 779–798. doi:10.1111/j.1600-0625.2007.00629.x
  • Sagi L, Trau H. (2011). The Koebner phenomenon. Clin Dermatol, 29, 231–236. doi:10.1016/j.clindermatol.2010.09.014
  • Schleicher SM. (2016). Psoriasis. Clin Podiatr Med Surg, 33, 355–366. doi:10.1016/j.cpm.2016.02.004
  • Schön MP, Boehncke W-H. (2005). Psoriasis. New England J Med, 352, 1899–1912. doi:10.1056/NEJMra041320
  • Siegel D, Devaraj S, Mitra A, et al. (2013). Inflammation, atherosclerosis, and psoriasis. Clin Rev Allergy Immunol, 44, 194–204. doi:10.1007/s12016-012-8308-0
  • Springall R, Amezcua-Guerra LM, Gonzalez-Pacheco H, et al. (2013). Interferon-gamma increases the ratio of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in peripheral monocytes from patients with coronary artery disease. PloS One, 8, e72291. doi:10.1371/journal.pone.0072291

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.